Dr. Bridgett A Alcorn, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1733 Teakwood Ln, Hebron, KY 41048 Phone: 317-362-5990 |
News Archive
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
About 15 years ago, Dr. Sue McElroy, a psychiatrist in Mason, Ohio, started noticing a pattern. People came to see her because they were depressed, but they frequently had a more visible ailment as well: They were heavy.
A new poll finds President Barack Obama's job-approval rating and favorability remain high - 56 and 61 percent, respectively - despite deep divides over his health care proposal and handling of the economy, Bloomberg reports.
U.S. News & World Report/HealthDay News reports that seniors who participate in Medicare Part D's will likely notice significant changes during this year's open enrollment period, which begins Nov. 15. "Monthly premiums will rise 11 percent to $38.94, on average, according to an analysis published by the Henry J. Kaiser Family Foundation. That's up 50 percent from 2006, the first year that Medicare Part D drug benefits were offered."
› Verified 5 days ago